ASSANTO, GIOVANNI MANFREDI

ASSANTO, GIOVANNI MANFREDI  

DIPARTIMENTO DI CHIRURGIA  

Mostra prodotti
Risultati 1 - 20 di 37 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autore(i) File
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al 2022 Serrao, Alessandra; Assanto, Giovanni Manfredi; Malfona, Francesco; Chavez Orellana, Gabriela; Chistolini, Antonio
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD 2024 Sorella, Silvia; Assanto, GIOVANNI MANFREDI; Maria D’Elia, Gianna; Annechini, Giorgia; Totaro, Matteo; Celia, Renata; Bruno, Leonardo; Placidi, Fabio; Martelli, Maurizio; DEL GIUDICE, Ilaria
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients? 2023 Pulsoni, A; Assanto, G M; Salvatori, M; Musiu, P; Luise, C; Passucci, M; Lapietra, G; Pappalardo, L; Annechini, G; D'Elia, G M; Martelli, M; Del Giudice, I
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients 2023 Chistolini, A; Serrao, A; Assanto, G M; Genoese, A; Baldacci, E; Ligia, S; Breccia, M; Santoro, C
Asciminib in chronic myeloid leukemia 2022 Assanto, Giovanni Manfredi; Scalzulli, Emilia; Breccia, Massimo
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 2023 Micozzi, Alessandra; Minotti, Clara; Capria, Saveria; Cartoni, Claudio; Trisolini, Silvia Maria; Assanto, Giovanni Manfredi; Barberi, Walter; Moleti, Maria Luisa; Santilli, Stefania; Martelli, Maurizio; Gentile, Giuseppe
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w) 2021 Bruzzese, A.; Assanto, G. M.; Diverio, D.; Quattrocchi, L.; Carmini, D.; La Rocca, U.; De Propris, M. S.; Trisolini, S. M.; Brescini, M.; Galassi, G.; Barberi, W.; Iori, A. P.
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients 2025 Biglietto, M.; Ligia, S.; Lagana, A.; Assanto, G. M.; Gherardini, M.; Baldacci, E.; Santoro, C.; Chistolini, A.
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies 2022 Serrao, Alessandra; Malfona, Francesco; Assanto, Giovanni Manfredi; Orellana, Maria Gabriela Chavez; Santoro, Cristina; Chistolini, Antonio
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome 2024 Ligia, Silvio; Passucci, Mauro; Assanto, Giovanni Manfredi; D'Elia Gianna Maria, ; Giorgia, Annechini; De Propris Maria Stefania, ; Martelli, Maurizio; Del Giudice, Ilaria; Tiacci, Enrico; Pulsoni, Alessandro
Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis 2024 Laganà, Alessandro; Assanto, Giovanni Manfredi; Passucci, Mauro; Santoro, Cristina; Chistolini, Antonio
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment 2022 Di Rocco, Alice; Petrucci, Luigi; Assanto, Giovanni Manfredi; Martelli, Maurizio; Pulsoni, Alessandro
EZH2 gene mutations and copy number variation as prognostic markers in advanced follicular lymphoma 2025 Assanto, GIOVANNI MANFREDI
Feasibility of Immunoglobulin Gene Rearrangement Tracking on Circulating Tumor DNA as an Outcome Predictor in Primary Mediastinal B-Cell Lymphoma 2026 Assanto, Gm; D'Antuono, I; Donzelli, L; Bellomarino, V; Della Starza, I; Antonacci, M; Cardinali, D; Ansuinelli, M; Petrucci, L; Di Rocco, A; Del Giudice, I; Martelli, M
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care 2022 Assanto, Giovanni Manfredi; Scalzulli, Emilia; Carmosino, Ida; Martelli, Maurizio; Breccia, Massimo
Hematopoietic Stem Cell Transplantation in Myelofibrosis: The Experience of Three University Transplant Centres in Rome 2020 Galassi, Giulia; Chiusolo, Patrizia; Cerretti, Raffaella; Barberi, Walter; Quattrocchi, Luisa; La Rocca, Ursula; Sora, Federica; Rossi, Valentina; Assanto, Giovanni Manfredi; Brescini, Mattia; Ricci, Roberto; Latagliata, Roberto; Breccia, Massimo; Arcese, William; Bacigalupo, Andrea; Sica, Simona; Iori, Anna Paola
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse 2021 Assanto, G. M.; Ciotti, G.; Brescini, M.; De Luca, M. L.; Annechini, G.; D'Elia, G. M.; Agrippino, R.; Del Giudice, I.; Martelli, M.; Chiaravalloti, A.; Pulsoni, A.
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study 2023 Assanto, G. M.; Di Rocco, A.; Malfona, F.; Capriata, M.; Del Giudice, I.; Petrucci, L.; Girardi, P.; D'Elia, G. M.; Martelli, M.; Gentile, G.; Micozzi, A.; Pulsoni, A.
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study 2022 Assanto, GIOVANNI MANFREDI; DI ROCCO, Alice; Malfona, Francesco; Capriata, Marcello; DEL GIUDICE, Ilaria; Petrucci, Luigi; Girardi, Paola; Maria D'elia, Gianna; Martelli, Maurizio; Gentile, Giuseppe; Micozzi, Alessandra; Pulsoni, Alessandro
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study 2024 Passucci, Mauro; Fazio, Francesca; Micozzi, Jacopo; Bafti, Manhaz Shafii; Assanto, Giovanni; Piciocchi, Alfonso; Martelli, Maurizio; Petrucci, Maria Teresa